Now showing items 1-2 of 2

    • A new cognitive evaluation battery for Down syndrome and its relevance for clinical trials 

      de Sola Llopis, Susana; De la Torre Fornell, Rafael; Sánchez Benavides, Gonzalo; Benejam, Bessy; Cuenca, Aída; del Hoyo, Laura; Rodríguez, Joan; Catuara-Solarz, Silvina; Sánchez-Gutiérrez, Judit; Dueñas-Espín, Ivan; Hernández, Gimena; Peña-Casanovas, Jordi; Langohr, Klaus; Videla, Sebastià; Blehaut, Henri; Farré, Magí; Dierssen, Mara (2015-06-04)
      Article
      Open Access
      The recent prospect of pharmaceutical interventions for cognitive impairment of Down syndrome (DS) has boosted a number of clinical trials in this population. However, running the trials has raised some methodological ...
    • Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial 

      De la Torre Fornell, Rafael; de Sola Llopis, Susana; Hernández, Gimena; Farré, Magí; Langohr, Klaus; Cuenca Royo, Aida; Xicota, Laura; Janel, Nathalie; Sanchez Benavides, Gonzalo; Blehaut, Henri; del Hoyo, Laura; Benejam, Bessy; Blanco Hinojo, Laura; Videla, Sebastià; Dierssen, Mara (2016-07-01)
      Article
      Open Access
      Background Early cognitive intervention is the only routine therapeutic approach used for amelioration of intellectual deficits in individuals with Down's syndrome, but its effects are limited. We hypothesised that ...